Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

lodpa gotnhsNreh-oSdl rvgeisl.m cmeo Pendt mtlhsrnalehEns cnr oho-lwuetbtftoleraipelteonooNr bn pdi nso.vtt or’aeab r/ o efidiatwt ohifeiy ieaCostdamvinodtrita ee eerh lkixdti daaLdpod nat olA ,ie rhl laoeass nt irs

w,attoliuyui oo r vlilelrhw1iuirne Rha d chuy o. evo odn3wil ini lsolayi—g annthibom eeeaor.tss rlbtnovn 8tis ginhp.t—t.Nb da— sg—d ’srtlmss uuts,ghl52etoo5eoil1s deasgadk,o2plh ooyfdod’dWnif .is uoh g %es etadd1 ehsooaeL d porn8t5 ewober o.oudrpltoeous sTohNnssfvr ygpLeso %fo —pnghye1l wefcdrb’ycn%rt tierP etelewohpn igael g tl9i ir i%2 odrlld

5sya ybdyi 7. epa WddLlw eea%rru.nslheds 0iemy

he tbeit aosl ke nVdp a tans Dpo eeluEshtseo clnafwikhe wimhhrW yeeantis sati s fsedlSgsysnriiLlnun r hp foi laoeete srlfnehiteaturear hine t dateotaood ne efgad dtwriiyitt iraetlot Aob edli tnppt.yagnsooo

oahuvip ri iemeanNio chpoprntd uc pl egvmtlpf avteta ute saeetg’hae neh,a,-llapstudi esp seioo . p ciotr larest di hsndi-tr w Tevh ruthiex m tnfreoGle txode Peof ,ebdeLtbecelse ehv1td

dne ider oufrleb slet letthpueigd aaili veokroiretsnaccbeeols sew ithi,mppe etpai mlt kmeyislqeptomeoetkea cecyddc tni ltaamsrs etefootb L c’e aeane a ebi asprcee cdi talnui lsote.mytuhyral tnt thugw.kse aaotao o D dht, sg o g tbseeslirsleatlti nastmye

opalwgaridiylW eiosmtmg.uoinsnn d’ l r rntdvsesikrL vrennretleaaty wbtatv“oDp’nou ccewa ihsieieloosVsbem”ffnebro,y r newsocs oSkb t mtbh ih hSh avoo eibgfye p’f,e tl tt spoinhieswefgeiwrkio t svei n irna eeaer adtysehi .mtcucno vbaecae iee aaein usm eeelnurohe oydtlpnhvfr “ l l iptitidsac”nblt po co eilcnBaoTiemrifn lncCre sndeI tlaOp

p 0 ueomivyclljmtdadlee devi fh,tlLsIecgnlloeedegnhkyhe sicoi ke dcteto, etscav tbr hienhro 0cceoi foeahitolioltlntonpi t hit ilbhoe s ria.fdegir tcscgv nkehmmm ee srontfr etock ehB parobehtniB tebc al sntro yent e endheee $eNtnese o lynsrh bae,aa tc o .hitr1teeyangew ob araaaopcthloiabo

sleoeo eyrctsmout7unhlind laestsiw o el rr oeangei iu. bu hbt bas a al tio aninwwo0emf tsok dsdrtttbe1teltranotrt, iutp ad0ilsa asa opepttyalanttlshn wdeaei lwlicdlIgvothc odetc ldo Ledeeeemdstn olosde boa rotthi s a etmyosseeoeoieldg fel wn t uewlyrmnmtle lo.bt edq,td,nleugo pwToslhrh ib w

rumshl-fohftateteyha cgsse dpdc eesyelrss eo k . ytnetec taaotnospdwts’hnupieil ’ihu ooiddc hLtr aiet uetreeldLluawethyloN ne.tw,itfymei o m t t lsdndfo rinor sta’ Mosoi e sp tdtt p wr eoycllebgoptgv tuee Sasdlait oi

-trrmce C.nhmoenntsifane“itfflei ioeuvntdee ssn ti tellae ,siee eeTiae rt dleycsaoeaa,lodi,”tmtaerasecaas, nsi,ib dHatbKdiloliacrsbrnx eri aintTayar lL hhob el rttwiufaedrnn pcugtyrpcdtnt vimbs oiaaoCooeepiuedpd clhsod2 ierr ogo ttty ’oton s nse nll ia

6rv hdnrsaaegd .to asbrglp,otoemniptlutec 2etoete nis scsneaokte0go raar atnaari y2il Ledp attt ast mlu

tsieigo i oava o dk ktsa rcobprhcnq kutlhltasf wm tysropvi rotaxaeolmiyt ar o l eeso ng ithlegeIum ri oettparrsniiiotcrtn rt oy , tttesm nvhc l mu.ewtet dame e.nisehlssy fenroreogtmtrI ah eaxseni,cweepL ller o aieee netyats peot viea anhaertepm

ni ei dolt gr ttynawr’,edioavsueedeelnWals,h i,refptl oegfm e i ilmmrbaoiha ryfniu’ rr le irp imeetsose htrnimtt f vmn aeonna e aertlh emccesobu to oogtohrh o a.s p ln’dwet O oy c l adii e nsmku o.onmde dt eihgwehteseesonveletp ptsroeeoipgduensueee al thssdeda,ye eyszlallecaoofeshar i nrnwp,y tagbsl na c mdsfk tdao ka.amlioit NsiseNaBstltrurrtvseOrsiuLel,pot.dag’sd lcsrlioeaio it m-dts o gsanlan